A citation-based method for searching scientific literature

David Isaacs, Jessie S Gibson, Jeffrey Stovall, Daniel O Claassen. J Huntingtons Dis 2020
Times Cited: 2







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals.
J B Penney, A B Young, I Shoulson, S Starosta-Rubenstein, S R Snodgrass, J Sanchez-Ramos, M Ramos-Arroyo, F Gomez, G Penchaszadeh, J Alvir. Mov Disord 1990
151
50


Comparative effectiveness of second-generation antipsychotics and haloperidol in acute schizophrenia.
Robert E McCue, Rubina Waheed, Leonel Urcuyo, Geraldine Orendain, Michel D Joseph, Richard Charles, Syed M Hasan. Br J Psychiatry 2006
51
50

Atypical movement disorders in the early stages of Huntington's disease: clinical and genetic analysis.
F Squitieri, A Berardelli, E Nargi, B Castellotti, C Mariotti, M Cannella, M L Lavitrano, U de Grazia, C Gellera, S Ruggieri. Clin Genet 2000
59
50

A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia.
N Quinn, C D Marsden. J Neurol Neurosurg Psychiatry 1984
71
50

A Prospective Pilot Trial for Pallidal Deep Brain Stimulation in Huntington's Disease.
Lars Wojtecki, Stefan J Groiss, Stefano Ferrea, Saskia Elben, Christian J Hartmann, Stephen B Dunnett, Anne Rosser, Carsten Saft, Martin Südmeyer, Christian Ohmann,[...]. Front Neurol 2015
37
50

Aripiprazole in the treatment of olanzapine-resistant psychotic and motor symptoms of Huntington's disease.
Panagiotis Oulis, Iraklis Mourikis, George Konstantakopoulos, Sokratis G Papageorgiou, Anastasios V Kouzoupis. J Neuropsychiatry Clin Neurosci 2010
8
50

Riluzole and olanzapine in Huntington's disease.
Raphael M Bonelli, G Niederwieser, J Diez, P Költringer. Eur J Neurol 2002
10
50

Olanzapine and Huntington's disease.
G Bogelman, S Hirschmann, I Modai. J Clin Psychopharmacol 2001
20
50

Improvement of Huntington's disease with olanzapine and valproate.
V E Grove, J Quintanilla, G T DeVaney. N Engl J Med 2000
59
50

Risperidone in chorea and psychosis of Huntington's disease.
A Kemal Erdemoglu, C Boratav. Eur J Neurol 2002
35
50

Rating Scales for Motor Symptoms and Signs in Huntington's Disease: Critique and Recommendations.
Tiago A Mestre, Maria João Forjaz, Philipp Mahlknecht, Francisco Cardoso, Joaquim J Ferreira, Ralf Reilmann, Cristina Sampaio, Christopher G Goetz, Esther Cubo, Pablo Martinez-Martin,[...]. Mov Disord Clin Pract 2018
11
50

Use of risperidone in psychosis associated with Huntington's disease.
S Madhusoodanan, R Brenner. Am J Geriatr Psychiatry 1998
31
50


Olanzapine for Huntington's disease: an open label study.
Raphael M Bonelli, Franz A Mahnert, Gerald Niederwieser. Clin Neuropharmacol 2002
42
50

Effectiveness of anti-psychotics and related drugs in the Huntington French-speaking group cohort.
Gaëlle Désaméricq, Guillaume Dolbeau, Christophe Verny, Perrine Charles, Alexandra Durr, Katia Youssov, Clémence Simonin, Jean-Philippe Azulay, Christine Tranchant, Cyril Goizet,[...]. PLoS One 2014
10
50

A randomized trial of amantadine in Huntington disease.
Padraig O'Suilleabhain, Richard B Dewey. Arch Neurol 2003
68
50

Treatment of huntington disease.
Aleksandar Videnovic. Curr Treat Options Neurol 2013
28
50

Quetiapine in Huntington's disease: a first case report.
Raphael M Bonelli, Gerald Niederwieser. J Neurol 2002
22
50



Motor speech patterns in Huntington disease.
Sarah K Diehl, Antje S Mefferd, Ya-Chen Lin, Jessie Sellers, Katherine E McDonell, Michael de Riesthal, Daniel O Claassen. Neurology 2019
7
50

Aripiprazole in the treatment of depressive and anxiety disorders: a review of current evidence.
Chi-Un Pae, Alessandro Serretti, Ashwin A Patkar, Praksh S Masand. CNS Drugs 2008
60
50

Deep brain stimulation for Huntington's disease: long-term results of a prospective open-label study.
Victoria Gonzalez, Laura Cif, Brigitte Biolsi, Sara Garcia-Ptacek, Anne Seychelles, Emily Sanrey, Irene Descours, Christine Coubes, Ana-Maria Ribeiro de Moura, Astrid Corlobe,[...]. J Neurosurg 2014
56
50

Wearable Sensors in Huntington Disease: A Pilot Study.
Kelly L Andrzejewski, Ariel V Dowling, David Stamler, Timothy J Felong, Denzil A Harris, Cynthia Wong, Hang Cai, Ralf Reilmann, Max A Little, Joseph T Gwin,[...]. J Huntingtons Dis 2016
29
50

Tics as an initial manifestation of juvenile Huntington's disease: case report and literature review.
Shi-Shuang Cui, Ru-Jing Ren, Ying Wang, Gang Wang, Sheng-Di Chen. BMC Neurol 2017
5
50

Unawareness of deficits in Huntington's disease.
Emilia J Sitek, Jennifer C Thompson, David Craufurd, Julie S Snowden. J Huntingtons Dis 2014
36
50

Short-term effects of olanzapine in Huntington disease.
F Squitieri, M Cannella, A Porcellini, L Brusa, M Simonelli, S Ruggieri. Neuropsychiatry Neuropsychol Behav Neurol 2001
67
50

Patient-reported impact of symptoms in Huntington disease: PRISM-HD.
Alistair M Glidden, Elizabeth A Luebbe, Molly J Elson, Steven B Goldenthal, Christopher W Snyder, Christine E Zizzi, E Ray Dorsey, Chad R Heatwole. Neurology 2020
12
50

Prospective evaluation of Globus pallidus internus deep brain stimulation in Huntington's disease.
S Zittel, V Tadic, C K E Moll, T Bäumer, A Fellbrich, A Gulberti, D Rasche, N Brüggemann, V Tronnier, A Münchau. Parkinsonism Relat Disord 2018
11
50


Effectiveness of risperidone in Huntington chorea patients.
C Dallocchio, C Buffa, C Tinelli, P Mazzarello. J Clin Psychopharmacol 1999
41
50

Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea.
Samuel Frank, David Stamler, Elise Kayson, Daniel O Claassen, Amy Colcher, Charles Davis, Andrew Duker, Shirley Eberly, Lawrence Elmer, Erin Furr-Stimming,[...]. JAMA Neurol 2017
25
50

Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease.
Theresa A Zesiewicz, Kelly L Sullivan, Robert A Hauser, Juan Sanchez-Ramos. Mov Disord 2006
19
50

Aripiprazole treatment for choreoathetoid and psychotic symptoms of Huntington's disease.
K F Yavuz, S Ulusoy, İ Alnıak. J Neuropsychiatry Clin Neurosci 2013
5
50

Asymptomatic sleep abnormalities are a common early feature in patients with Huntington's disease.
Anna O G Goodman, Lorraine Rogers, Samantha Pilsworth, Catherine J McAllister, John M Shneerson, A Jennifer Morton, Roger A Barker. Curr Neurol Neurosci Rep 2011
67
50

Psychosis.
David B Arciniegas. Continuum (Minneap Minn) 2015
30
50

Olanzapine in Huntington's disease.
D Paleacu, M Anca, N Giladi. Acta Neurol Scand 2002
51
50

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.
Samuel Frank, Claudia M Testa, David Stamler, Elise Kayson, Charles Davis, Mary C Edmondson, Shari Kinel, Blair Leavitt, David Oakes, Christine O'Neill,[...]. JAMA 2016
99
50

What effect does a structured home-based exercise programme have on people with Huntington's disease? A randomized, controlled pilot study.
Hanan Khalil, Lori Quinn, Robert van Deursen, Helen Dawes, Rebecca Playle, Anne Rosser, Monica Busse. Clin Rehabil 2013
69
50

Evaluating depression and suicidality in tetrabenazine users with Huntington disease.
Jordan L Schultz, Annie Killoran, Peg C Nopoulos, Chloe C Chabal, David J Moser, John A Kamholz. Neurology 2018
11
50

An International Survey-based Algorithm for the Pharmacologic Treatment of Chorea in Huntington's Disease.
Jean-Marc Burgunder, Mark Guttman, Susan Perlman, Nathan Goodman, Daniel P van Kammen, Lavonne Goodman. PLoS Curr 2011
56
50

A Europe-wide assessment of current medication choices in Huntington's disease.
Josef Priller, Daniel Ecker, Bernhard Landwehrmeyer, David Craufurd. Mov Disord 2008
30
50

Physician perceptions of pharmacologic treatment options for chorea associated with Huntington disease in the United States.
Victor W Sung, Ravi G Iyer, Sanjay K Gandhi, Bijal Shah-Manek, Marco DiBonaventura, Victor Abler, Daniel O Claassen. Curr Med Res Opin 2018
3
50

Cortical myoclonus in Huntington's disease.
P D Thompson, K P Bhatia, P Brown, M B Davis, M Pires, N P Quinn, P Luthert, M Honovar, M D O'Brien, C D Marsden. Mov Disord 1994
42
50

The trial use of clozapine for abnormal involuntary movement disorders.
E D Caine, R J Polinsky, R Kartzinel, M H Ebert. Am J Psychiatry 1979
140
50

Exercise effects in Huntington disease.
Sebastian Frese, Jens A Petersen, Maria Ligon-Auer, Sandro Manuel Mueller, Violeta Mihaylova, Saskia M Gehrig, Veronika Kana, Elisabeth J Rushing, Evelyn Unterburger, Georg Kägi,[...]. J Neurol 2017
21
50

Tetrabenazine Versus Deutetrabenazine for Huntington's Disease: Twins or Distant Cousins?
Filipe B Rodrigues, Gonçalo S Duarte, João Costa, Joaquim J Ferreira, Edward J Wild. Mov Disord Clin Pract 2017
25
50

A randomized feasibility study of a 12-week community-based exercise program for people with Huntington's disease.
Monica Busse, Lori Quinn, Katy Debono, Karen Jones, Johnathan Collett, Rebecca Playle, Mark Kelly, Sharon Simpson, Karianne Backx, David Wasley,[...]. J Neurol Phys Ther 2013
64
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.